Bionpharma's Metformin Hydrochloride ANDA219151 Receives AP Status
Bionpharma's Abbreviated New Drug Application (ANDA219151) for Metformin Hydrochloride has received an Approval Pending (AP) status from the FDA.
Asset / Drug
Drug and asset intelligence for Bionpharma with 1 indexed intelligence signal across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.